Clinical Trial Update: A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of mitoxantrone hydrochloride liposome injection in advanced recurrent or metastatic breast cancer is being conducted; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Recurrent or Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN